| abstract |
Disclosed are compositions and methods for the treatment, prevention, and amelioration of symptoms and diseases characterized by reduced white blood cell counts. The methods and compositions described herein comprise a fusion polypeptide formed from human serum albumin protein (“HSA”) and human granulocyte colony stimulating factor (“G-CSF”). |